chartexchange

ELVN
Enliven Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:52 PM EST
44.91USD-4.141%(-1.94)747,613
After-hoursNov 18, 2026 4:00:30 PM EST
44.89USD-0.045%(-0.02)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Boulder, CO, USA
Previous Close
$46.85
Beta
1.15
52-Week High
$62.32 2026-08-05
52-Week Low
$14.79 2026-01-06
SMA 50
$45.69
SMA 200
$44.12
Avg. Vol 10D
896,987
Avg. Vol 30D
1.41M
Avg. Vol 90D
1.23M
Relative Vol
0.53
46.99M
10,293,807
0.4100%
4,305
ELVN Profile

enliven therapeutics focuses on the discovery and development of next generation small molecule treatments for cancer. we are backed by top-tier life science venture funds. we seek experienced and passionate drug hunters to join our team as we grow our r&d organization in boulder, co.

ELVN Performance
PeriodPriceDateChangeBeta
1W48.312026-11-12-7.02%0.416
1M38.702026-10-19+16.07%1.677
3M59.392026-08-19-24.36%1.362
6M40.172026-05-19+11.82%0.995
1Y22.102025-11-19+103.26%1.148
2Y26.182024-11-19+71.58%—
5Y21.002023-02-27+113.91%1.317
ELVN Stock Summary

Enliven Therapeutics, Inc. Common Stock (NASDAQ:ELVN) stock price today is $44.92, and today's volume is 747,613. ELVN is down 4.120% today. The 30 day average volume is 1.41M. ELVN market cap is $3.31B with 73.60M shares outstanding.